Translator Disclaimer
1 April 2014 Stable Reporter Gene Assay Based on Gal4—Vitamin D Receptor β Fusion Proteins in Medaka (Oryzias latipes), and Its Transactivational Properties
Author Affiliations +
Abstract

The transactivational property of natural and synthetic chemicals via medaka vitamin D receptor β subtype (VDRβ) was investigated after the development of a stable cell line expressing a Gal4-VDRβ fusion protein for reporter gene assay. Members of vitamin D class, including 1α, 25- dihydroxyvitamin D3 (1,25VD3) were specifically detected as agonists in our system. Although other steroids and chemicals used in the present estimation induced no agonistic response, 10 compounds displayed antagonistic or synergistic activity. Spironolactone, which is an antagonist of corticoid receptors in mammals, competitively inhibited the transactivity of 1,25VD3 by over 80% in a dosedependent manner. Mifepristone and cyproterone acetate were also detected as antagonists, but they significantly acted only at 10µ. Pregnenolone and raloxifene dose-dependently enhanced the activity of 1,25VD3 at EC50 to the maximum level. Diethylstilbestrol, 17α-ethynylestradiol, genistein, and stanozolol were also synergists, but their potency was low. Interestingly, dibutyltin dichloride, which is used as a stabilizer in the production of polyvinyl chloride plastics, produced greater response than maximum effect of 1,25VD3 although the concentration-response curve was not typically sigmoidal. In the present study, we successfully developed a stable reporter gene assay, which allows assessment of the vitamin D-like chemicals toward the medaka VDRβ.

© 2014 Zoological Society of Japan
Atsushi Tanago and Toshitaka Ikeuchi "Stable Reporter Gene Assay Based on Gal4—Vitamin D Receptor β Fusion Proteins in Medaka (Oryzias latipes), and Its Transactivational Properties," Zoological Science 31(4), 195-201, (1 April 2014). https://doi.org/10.2108/zs130217
Received: 24 October 2013; Accepted: 1 December 2013; Published: 1 April 2014
JOURNAL ARTICLE
7 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top